How Analysts Feel About Perrigo Company plc (NYSE:PRGO)?

September 16, 2018 - By Anthony Romero

Perrigo Company plc (NYSE:PRGO) LogoInvestors sentiment increased to 1.18 in Q2 2018. Its up 0.30, from 0.88 in 2018Q1. It is positive, as 36 investors sold Perrigo Company plc shares while 104 reduced holdings. 47 funds opened positions while 118 raised stakes. 105.75 million shares or 2.70% more from 102.96 million shares in 2018Q1 were reported.
Cibc Mkts owns 133,144 shares or 0.04% of their US portfolio. Clal owns 1.96 million shares. Credit Suisse Ag accumulated 178,887 shares. Voloridge Invest invested 0.31% in Perrigo Company plc (NYSE:PRGO). Sector Gamma As, a Norway-based fund reported 199,440 shares. Jacobs Levy Equity Mngmt Inc has 0.01% invested in Perrigo Company plc (NYSE:PRGO) for 6,440 shares. Natl Bank Of Ny Mellon Corporation owns 1.06M shares. 8,148 were reported by Stifel Fincl. State Of New Jersey Common Pension Fund D holds 50,000 shares. Pdt Partners Ltd Llc has invested 0.91% in Perrigo Company plc (NYSE:PRGO). 4,350 are owned by Bessemer Group. Natl Bank Of Nova Scotia invested in 3,629 shares or 0% of the stock. D E Shaw accumulated 876,347 shares or 0.08% of the stock. Grp One Trading Ltd Partnership reported 8,244 shares or 0.01% of all its holdings. Ameriprise Financial owns 721,007 shares or 0.02% of their US portfolio.

Perrigo Company plc (NYSE:PRGO) Ratings Coverage

Among 9 analysts covering Perrigo Company plc (NYSE:PRGO), 1 have Buy rating, 1 Sell and 7 Hold. Therefore 11% are positive. Perrigo Company plc had 11 analyst reports since May 8, 2018 according to SRatingsIntel. Deutsche Bank downgraded it to “Hold” rating and $78 target in Friday, August 10 report. Cantor Fitzgerald maintained the shares of PRGO in report on Tuesday, May 8 with “Buy” rating. The stock of Perrigo Company plc (NYSE:PRGO) has “Market Perform” rating given on Monday, May 14 by Wells Fargo. Wells Fargo maintained Perrigo Company plc (NYSE:PRGO) rating on Tuesday, August 21. Wells Fargo has “Market Perform” rating and $77 target. Barclays Capital downgraded the shares of PRGO in report on Wednesday, June 6 to “Equal-Weight” rating. On Friday, August 10 the stock rating was maintained by JP Morgan with “Neutral”. The firm earned “Hold” rating on Monday, July 30 by Argus Research. Goldman Sachs downgraded the stock to “Sell” rating in Thursday, July 12 report. The stock has “Buy” rating by Cantor Fitzgerald on Monday, May 14. As per Friday, August 10, the company rating was maintained by RBC Capital Markets. Below is a list of Perrigo Company plc (NYSE:PRGO) latest ratings and price target changes.

21/08/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $84 New Target: $77 Maintain
10/08/2018 Broker: RBC Capital Markets Old Rating: Sector Perform New Rating: Sector Perform Old Target: $89 New Target: $67 Maintain
10/08/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $83 New Target: $75 Maintain
10/08/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Hold Old Target: $93 New Target: $78 Downgrade
30/07/2018 Broker: Argus Research Old Rating: Buy New Rating: Hold Downgrade
12/07/2018 Broker: Goldman Sachs Old Rating: Neutral New Rating: Sell Old Target: $78 New Target: $74 Downgrade
18/06/2018 Broker: Morgan Stanley Rating: Hold New Target: $85.0000
06/06/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal-Weight Old Target: $110 Downgrade
14/05/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $107.0000 Maintain
14/05/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $90 New Target: $84 Maintain

The stock decreased 2.44% or $1.84 during the last trading session, reaching $73.69. About 1.58 million shares traded or 10.23% up from the average. Perrigo Company plc (NYSE:PRGO) has declined 15.60% since September 16, 2017 and is downtrending. It has underperformed by 31.22% the S&P500.

Perrigo Company plc, together with its subsidiaries, develops, makes, markets, and distributes over-the-counter consumer goods and pharmaceutical products worldwide. The company has market cap of $10.08 billion. It offers OTC products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. It has a 44.1 P/E ratio. The firm also provides generic and specialty pharmaceutical prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations.

Another recent and important Perrigo Company plc (NYSE:PRGO) news was published by Benzinga.com which published an article titled: “Health Care Has Been On Fire. Will The Uptrend Continue?” on September 07, 2018.

Perrigo Company plc (NYSE:PRGO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.